ArticleACG case reports journal2026
Endoscopic Sleeve Gastroplasty Combined With GERDx Endoscopic Full-Thickness Plication for Obesity-Associated Mechanical GERD: A Dual-Mechanism Endoscopic Case Series.
Article in ACG case reports journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Obesity-associated gastroesophageal reflux disease (GERD) is often driven by mechanical factors including increased intra-abdominal pressure, hiatal hernia, and gastroesophageal junction dysfunction. Endoscopic sleeve gastroplasty (ESG) reduces gastric volume and intragastric pressure, whereas endoscopic full-thickness plication (eFTP) reinforces the antireflux barrier. However, data on the intentional combination of these interventions remain limited. This retrospective case series included 9 patients with overweight or obesity and proton pump inhibitor-refractory GERD who underwent same-session ESG and GERDx eFTP at a tertiary endoscopy center. eFTP was performed first, followed by ESG during the same session. All procedures were completed successfully without adverse events. Follow-up (1 month-2 years) demonstrated weight loss, improvement in reflux symptoms, and reduced proton pump inhibitor use. Repeat physiologic testing in selected patients showed improvement in DeMeester scores and esophageal acid exposure. Combined ESG and GERDx eFTP may represent a minimally invasive strategy addressing both intragastric pressure and gastroesophageal junction dysfunction in obesity-associated GERD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.